Synutra International, the Chinese infant formula maker, has swung to a profit in its fiscal first quarter.
For the three months to the end of June, the company made a profit of US$10.1m compared to a net loss of $9.9m in the prior year period.
Go deeper with GlobalData
Operating income reached $16.3m in the quarter, compared with an operating loss of $10.6m last year. Net sales increased 77% to $83.8m.
Liang Zhang, chairman and CEO of Synutra, said: “Last quarter marked the significant milestone of our return to profitability. This quarter, we have continued to leverage our robust information network and innovative, consumer driven marketing strategy to further improve our revenue mix and drive profitability.”
The company was yesterday forced to issue a statement criticising “irresponsible” reports in China that have alleged a link between the group’s formula and premature breast development in girls.
See Also:
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
